Skip to Main Content
Skip Nav Destination

Medical Cannabis and Cannabinoids

Editor: Brenneisen, R. (Bern)

Editorial Board

Submit manuscript

International Forum Examining Cannabis for Medical Purposes

Medical Cannabis and Cannabinoids is a peer-reviewed journal offering an international forum to present and discuss recent advances in the rapidly developing and challenging field of the medical use of cannabis and cannabinoids. It seeks to bridge the gap between empirical and evidence-based clinical medicine by covering current basic and applied as well as translational research topics. In addition to original papers, reviews, and mini-reviews, this journal features short communications, case reports, technical notes, letters, and conference proceedings.

About this Journal

Calls for Papers

See the latest calls for papers from our extensive journal range.


Journal Details

For Authors

Publish your paper with us.

Author Guidelines

Cost of Publication

Editors and Reviewers

Login to our peer review system.


Logo of the The CannX International Medical Cannabis Conference Series

The CannX International Medical Cannabis Conference Series

News & Highlights

Banner CCORC 2024

CCORC 2024

The Consortium for Medical Marijuana Clinical Outcomes Research is excited to announce that the 2024 Cannabis Clinical Outcomes Research Conference (CCORC) will be taking place from May 30th to May 31st, in Orlando, Florida.

More Information

Logo CANNabinoid Drug Interaction Review

New Tool for Evaluating Potential Drug-Drug Interactions Based on Cannabinoids

CANNabinoid Drug Interaction Review (CANN-DIR®), developed at Penn State College of Medicine, is intended to evaluate for potential drug-drug interactions based on the cannabinoids (THC & CBD) affecting the metabolism of OTHER concomitantly prescribed medications. This tool has been developed for use by healthcare providers, patients, caregivers, and interested community members. Medical Cannabis and Cannabinoids has published a product review on this tool: Drug Interaction Review (CANN-DIR), utilizing research published in the review Delta-9-Tetrahydrocannabinol and Cannabidiol Drug-Drug Interactions, appearing earlier in the journal.

Try the tool

Congress Announcements

Have a look at all events related to this journal.

View more

Issues & Articles

Connect with Us

Follow us on X

Check out our X feed.

Follow us

Stay Up-to-Date

Get news according to your interests.


Recommend this Journal

Suggest this journal via social media or e-mail to your colleagues.

Close Modal

or Create an Account

Close Modal
Close Modal